HKPD
HKPD
NASDAQ · Logistics & Transportation

Cellyan Biotechnology Co-A

$1.62
+0.09 (+5.88%)
As of Nov 14, 2:47 AM ET ·
Financial Highlights (FY 2026)
Revenue
2.66M
Net Income
-5,822
Gross Margin
21.8%
Profit Margin
8.0%
Rev Growth
—
D/E Ratio
0.48
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 21.8% 50.8% 50.8% 50.8%
Operating Margin 8.3% 13.2% 12.8% 14.3%
Profit Margin 8.0% 10.5% 9.0% 11.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 2.66M 7.40M 6.68M 7.22M
Gross Profit 579.8K 3.76M 3.39M 3.67M
Operating Income 220.9K 979.4K 856.8K 1.03M
Net Income -5,822 776.7K 602.4K 808.7K
Gross Margin 21.8% 50.8% 50.8% 50.8%
Operating Margin 8.3% 13.2% 12.8% 14.3%
Profit Margin 8.0% 10.5% 9.0% 11.2%
Rev Growth — +0.0% +3.7% -6.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 608.3K 3.92M 3.96M 4.01M
Total Equity 1.28M 6.40M 7.03M 7.28M
D/E Ratio 0.48 0.61 0.56 0.55
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 255.2K 1.39M 1.13M 1.38M
Free Cash Flow — 667.3K 430.6K 626.2K